CME/CE – Conference Highlights: IDWeek 2016

CME/CE – Conference Highlights: IDWeek 2016
Target Audience (click to view)

This activity is designed to meet the needs of physicians and nurses.

Learning Objectives(click to view)

Upon completion of the educational activity, participants should be able to:

 

  • Discuss the key findings of five studies presented at the 2016 joint annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society.

Method of Participation(click to view)

Release Date: 02/08/2017

Expiration Date: 02/08/2018

Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation.  A statement of credit will be available upon completion of an online evaluation/claimed credit form at http://akhcme.com/akhcme/lessons/16.  You must participate in the entire activity to receive credit.  If you have questions about this CME/CE activity, please contact AKH Inc. at dcotterman@akhcme.com.

Credit Available(click to view)

AKH

CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

 

Nursing
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is awarded 0.5 contact hours.

Commercial Support(click to view)

There is no commercial support for this activity.

Disclosures(click to view)

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use & Investigational Product(click to view)

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer(click to view)

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Faculty & Credentials(click to view)

Christopher Cole – Managing Editor
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH and PHYSICIAN WEEKLY’S STAFF/REVIEWERS

Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH planners and reviewers have no relevant financial relationships to disclose.

Share on FacebookTweet about this on TwitterShare on LinkedIn

New research was presented at IDWeek 2016, the combined annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, HIV Medicine Association, and Pediatric Infectious Diseases Society, from October 26-30 in New Orleans. The features below highlight some of the studies presented at the conference.

—————————————————————-


Patient- and Environment-to-Nurse Pathogen Transmission

Data are lacking on the transmission of pathogens to healthcare professionals from patients and patients’ environments. For a study, researchers obtained cultures from 40 nurses’ scrubs, 167 patients, and the patients’ rooms during three separate, 12-hour ICU shifts. All nurses used new scrubs for each shift. During these shifts, 22 confirmed transmissions were observed, among which six were from patient to nurse, six were from environment to nurse, and 10 were from patient to environment. No nurse-to-patient or nurse-to-environment transmissions were observed.

—————————————————————-

 

Outcomes With Rapid Microarray Testing

An available gram-negative blood culture test is able to detect four gram-negative genera, four species, and six resistance genes within 2 hours of blood culture positivity. The impact of pairing this test with an antimicrobial stewardship intervention on antimicrobial and clinical outcomes has not been well defined. Study investigators compared patients admitted with a blood culture positive for a gram-negative organism during the 6 months before (pre group) and after (post group) use of this microarray test as part of an antimicrobial stewardship intervention. The number and type of antimicrobial switches were similar between the groups, as were in-hospital mortality rates. However, median time from gram stain to antimicrobial switch was significantly decreased in the post group. Median time to active therapy among patients on inactive antimicrobial was also shorter for the post group. The post group also had a shorter median hospital length of stay.

—————————————————————-


Antibiotic Prescribing Upon Hospital Discharge

Few studies have characterized and determined the rate of inappropriate antimicrobial prescribing at hospital discharge. For a study, antimicrobial appropriateness was examined among randomly selected patients prescribed an antimicrobial at discharge. For patients discharged on antibiotics, 7- and 30-day readmission rates were 6.4% and 19.4%, respectively, compared with hospital-wide rates of 3.7% and 13.8%, respectively. Of patients discharged on antibiotics, 22% had no clinical indication of infection, 13% had an antibiotic with an inappropriate spectrum of activity, 17% received the incorrect dose, 55% received an antibiotic course that was too long, and 7% received a course that was too short.

—————————————————————-

 

CKD & Hepatitis C

Data are lacking on the effects of chronic kidney disease (CKD) on the incidence of hepatic and extra-hepatic outcomes in this patient population. Researchers compared rates of anemia, hyperbilirubinemia, end-stage liver disease, cryoglobulinemia, hepatocellular carcinoma (HCC), and mortality between patients with hepatitis C and CKD or hepatitis C alone. Patients with both conditions had a 61% higher mortality rate, an 85% higher rate of liver transplant recommendations, and more than two-fold higher rates of anemia and cryoglobulinemia. CKD was not found to be associated with increased risks for hyperbilirubinemia or HCC.

—————————————————————-

 

Identifying PrEP Candidates

A lack of sexual health and risk evaluations conducted as part of routine care has been identified as a barrier to initiating pre-exposure prophylaxis (PrEP) in more patients at high-risk for HIV infection. Researchers developed an automated algorithm to identify people at higher risk for acquiring HIVusing routinely collected information in electronic medical records. The study team looked at more than 100 variables—including demographics, diagnoses, drug prescriptions, laboratory tests, and procedures—among 138 patients with HIV and 13,800 matched controls. Using logistic regression modeling and machine learningto predict incident HIV infections among cases versus controls, the authors found that their machine learning algorithm was able to identify those who were likely to at higher risk for HIV infection and therefore candidates for PrEP.

 

NEWS FROM IDWEEK 2016

Always-Deadly Measles Complication More Common Than Believed

New Drug Benefits Patients with Multi-Drug Resistant HIV

Regular Dental Visits May Help Prevent Pneumonia, Study Shows

STIs Jump in Men With HIV, or on PrEP

Heart Surgery Machines Tied to M. chimaera Outbreak

New Drug Combo Succeeds in Tx-Resistant UTI, Kidney Infection

Ohio Sees Rapid Rise in Tx-Resistant Gonorrhea

VIDEO: Molecular Analysis of Transmission Events in the Antimicrobial Scrub and Transmission (ASCOT) Trial

VIDEO: Subacute Sclerosing Panencephalitis: the Devastating Measles Complication is More Common than We Think (Part 1)

VIDEO: Subacute Sclerosing Panencephalitis: the Devastating Measles Complication is More Common than We Think (Part 2)

VIDEO: Primary Efficacy Endpoint and Safety Results of Ibalizumab (IBA) in a Phase 3 Study of Heavily Treatment-Experienced Patients with Multi-Drug Resistant (MDR) HIV-1 Infection (Part 1)

VIDEO: Primary Efficacy Endpoint and Safety Results of Ibalizumab (IBA) in a Phase 3 Study of Heavily Treatment-Experienced Patients with Multi-Drug Resistant (MDR) HIV-1 Infection (Part 2)

VIDEO: Access to Dental Care and Risk of Pneumonia: The Importance of Healthy Teeth

Utah Zika Case: Healthcare Workers Deemed Safe

Despite Challenges, Hope Remains for Zika Vaccine

IDWeek Digs Deep Into Zika

Dolutegravir Regimen Works Better than Atazanavir in Clinical Trial for Women

Antimicrobial Shortages Continue, Linked to Poor Patient Outcomes

Do HIV-Positive Men with Undetectable Viral Load Need to Wear Condoms?

Only a Small Proportion of HIV+ Gay Men Receive Anal Cancer Screening

Ibalizumab Monoclonal Antibody Looks Promising for HIV Patients Left Behind

Are Antibiotics Useful for Small Skin Abscesses? Now There’s an Answer

 

Submit a Comment

Your email address will not be published. Required fields are marked *

seventeen − eight =